New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccinationFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Evaluating vaccination strategies for tuberculosis in endemic and non-endemic settingsFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Affordability of adult tuberculosis vaccination in India and China: A dynamic transmission model-based analysisFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
BCG and new preventive tuberculosis vaccines: Implications for healthcare workers.Friday, August 9, 2024Accessibility, Implementation strategies and feasibilityRead More
The health and economic benefits possible with novel tuberculosis vaccines – A modeling study in India and IndonesiaFriday, August 9, 2024Availability, Epidemiological impactRead More
Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and IndiaFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio.Friday, August 9, 2024Availability, Epidemiological impactRead More
Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccineFriday, August 9, 2024Availability, Epidemiological impactRead More
Formative work to understand factors affecting future TB vaccines acceptanceFriday, August 9, 2024Acceptability, Acceptability and demand, Acceptability and demand, Accessibility, Health system readiness, Health system readinessRead More
Estimating the epidemiologic impact of new TB vaccines in high-burden settingsFriday, August 9, 2024Availability, Epidemiological impactRead More
